About PaxMedica
PaxMedica is a company based in Woodcliff Lake (United States) founded in 2018.. PaxMedica has raised $3 million across 2 funding rounds from investors including The Lind Partners. PaxMedica operates in a competitive market with competitors including Nura Bio, Healx, NEOS Therapeutics, Blackthorn Therapeutics and STALICLA, among others.
- Headquarter Woodcliff Lake, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Paxmedica, Inc.
-
Annual Revenue
$00as on Dec 31, 2023
-
Net Profit
$-18.29 M-23.56as on Dec 31, 2023
-
EBITDA
$-16.15 M-52.25as on Dec 31, 2023
-
Total Equity Funding
$3 M (USD)
in 2 rounds
-
Latest Funding Round
$3.2 M (USD), Post-IPO
Feb 03, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PaxMedica
PaxMedica is a publicly listed company on the OTC with ticker symbol PXMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Advisor Team
6 people
Leadership Team
4 people
Finance and Accounting
1 people
Corporate Team
1 people
Unlock access to complete
Funding Insights of PaxMedica
PaxMedica has successfully raised a total of $3M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $3.2 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $3.2M
-
First Round
First Round
(06 Nov 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Post-IPO - PaxMedica | Valuation |
investors |
|
| Nov, 2020 | Amount | Seed - PaxMedica | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PaxMedica
PaxMedica has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Lind Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
The Lind Partners is based in New York, USA.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PaxMedica
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PaxMedica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Paxmedica Comparisons
Competitors of PaxMedica
PaxMedica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nura Bio, Healx, NEOS Therapeutics, Blackthorn Therapeutics and STALICLA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic solutions and neuroprotective medicines for neurological disorders are provided.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for rare diseases is developed.
|
|
| domain | founded_year | HQ Location |
Proprietary platform is utilized for extended-release CNS drug development.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurodevelopmental disorders are developed through the INFORM platform.
|
|
| domain | founded_year | HQ Location |
Precision medicines for neurodevelopmental disorders are manufactured using DEPI technology.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for CNS disorders are developed by SciNeuro.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Paxmedica
Frequently Asked Questions about PaxMedica
When was PaxMedica founded?
PaxMedica was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is PaxMedica located?
PaxMedica is headquartered in Woodcliff Lake, United States. It is registered at Woodcliff Lake, New Jersey, United States.
Is PaxMedica a funded company?
PaxMedica is a funded company, having raised a total of $3M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Nov 06, 2020.
What does PaxMedica do?
PaxMedica was founded in 2018 in Woodcliff Lake, United States, focusing on the biotechnology sector. Drug development efforts are centered on neurodevelopmental disorders, with pipeline candidates including PAX-101, an intravenous suramin formulation for early-stage Human African Trypanosomiasis, and PAX-102, an intranasal suramin version targeted at autism spectrum disorder and related conditions. Operations involve proprietary formulations for these therapeutic areas.
Who are the top competitors of PaxMedica?
Is PaxMedica publicly traded?
Yes, PaxMedica is publicly traded on OTC under the ticker symbol PXMD.
Who are PaxMedica's investors?
PaxMedica has 1 investor. Key investors include The Lind Partners.
What is PaxMedica's ticker symbol?
The ticker symbol of PaxMedica is PXMD on OTC.